C0026850 - The term dystrophy means abnormal growth. However, muscular dystrophy is used to describe primary myopathies with a genetic basis and a progressive course characterized by progressive skeletal muscle weakness and wasting, defects in muscle proteins, and histological features of muscle fiber degeneration (necrosis) and regeneration. If possible, it is preferred to use other HPO terms to describe the precise phenotypic abnormalities. [HPO:probinson, Neuromics:vstraub] 1/10
home    UMLS 2020

293,031 терминов и синонимов из MeSH и LOINC

Поиск по CUI
Поиск по CODE


Поиск по одному или нескольким словам или частям слов
   


Lang   Dictionary       CODE         LUI      
preferred
no
        SUI   preference
Yes / No
Terms, descriptions
CUI    C0026850
RussianMedical Subject Headings Russian D009136 L3358958preferred S3886444 Y МЫШЕЧНЫЕ ДИСТРОФИИ
RussianMedical Subject Headings Russian D009136 L0899802no S1103619 Y MYSHECHNAIA DISTROFIIA
RussianMedical Subject Headings Russian D009136 L1531394no S1827303 Y MYSHECHNYE DISTROFII
RussianMDRRUS 10028356 L15714784no S19048015 N Мышечная дистрофия
RussianMDRRUS 10028356 L15714784no S19048015 Y Мышечная дистрофия
RussianMDRRUS 10028357 L15770100no S19048014 Y Мышечная дистрофия, БДУ
RussianMedical Subject Headings Russian D009136 L3358928no S3886414 Y МЫШЕЧНАЯ ДИСТРОФИЯ
Medical Subject Headings A0088815 AT43116961 A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS.
(CPTSP) CRISP Thesaurus A0484297 AT51218731 general term for a group of inherited disorders which are characterized by progressive degeneration of skeletal muscles.
Medical Subject Headings Czech A13067023 AT231357937 Heterogenní skupina dědičných myopatií, projevujících se úbytkem a slabostí kosterního svalstva. Jsou rozděleny do kategorií podle místa výskytu svalové slabosti, věku nástupu a typu dědičnosti.
NCI Thesaurus A17697907 AT197999148 A group of inherited progressive muscle disorders characterized by muscle weakness and eventual death of the muscle tissues. Examples include Duchenne muscular dystrophy, Becker's muscular dystrophy, Emery-Dreifuss muscular dystrophy, facioscapulohumeral muscular dystrophy, and limb-girdle muscular dystrophy.
CHV A18555728 AT130671740 an inherited disease where skeletal muscles are progressively weakened and wasted.
CHV A18592813 AT130671741 an inherited disease where skeletal muscles are progressively weakened and wasted.
CHV A18611452 AT130671742 an inherited disease where skeletal muscles are progressively weakened and wasted.
CHV A18648618 AT130671743 an inherited disease where skeletal muscles are progressively weakened and wasted.
MSHNOR A20206673 AT221393243 En heterogen gruppe arvelige muskelsykdommer som kjennetegnes av muskelsvinn og svakhet i skjelettmuskulaturen. De er kategorisert etter hvor muskelsvakheten oppstår, debutalder og arvelighetsmønstre.
MEDLINEPLUS A21145492 AT203073206

Muscular dystrophy (MD) is a group of more than 30 inherited diseases. They all cause muscle weakness and muscle loss. Some forms of MD appear in infancy or childhood. Others may not appear until middle age or later. The different types can vary in whom they affect, which muscles they affect, and what the symptoms are. All forms of MD grow worse as the person's muscles get weaker. Most people with MD eventually lose the ability to walk.

There is no cure for muscular dystrophy. Treatments can help with the symptoms and prevent complications. They include physical and speech therapy, orthopedic devices, surgery, and medications. Some people with MD have mild cases that worsen slowly. Others cases are disabling and severe.

NIH: National Institute of Neurological Disorders and Stroke

HPO A24666524 AT206288889 The term dystrophy means abnormal growth. However, muscular dystrophy is used to describe primary myopathies with a genetic basis and a progressive course characterized by progressive skeletal muscle weakness and wasting, defects in muscle proteins, and histological features of muscle fiber degeneration (necrosis) and regeneration. If possible, it is preferred to use other HPO terms to describe the precise phenotypic abnormalities. [HPO:probinson, Neuromics:vstraub]